• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类骨髓移植后各阶段骨髓来源的成纤维细胞基质细胞的受体来源

Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans.

作者信息

Agematsu K, Nakahori Y

机构信息

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.

出版信息

Br J Haematol. 1991 Nov;79(3):359-65. doi: 10.1111/j.1365-2141.1991.tb08041.x.

DOI:10.1111/j.1365-2141.1991.tb08041.x
PMID:1751363
Abstract

The bone marrow microenvironment, which is composed of fibroblasts, endothelial cells, adipocytes and macrophages, plays an important role in the haematopoiesis and lymphopoiesis by producing various cytokines. Therefore, investigation of the origin of these cells following allogeneic bone marrow transplantation (BMT) is very significant, in terms of the haematological and immunological reconstitution after BMT. We have investigated the origin of fibroblastic stromal cells in long-term cultures in seven of the sex-mismatched cases. This was carried out by in situ hybridization using a Y-chromosome specific cDNA probe (PHY10), conserving the morphology of the cells. In situ hybridization analysis showed that bone marrow fibroblasts (BMF) in long-term cultures in all the sex-mismatched cases originated from the recipients. We have also performed Southern blot analysis using a PHY10 probe in the sex-mismatched cases and using a variable number of tandem repeats (VNTR) probe, which can detect DNA polymorphisms, in two fo the sex-matched cases. In addition, we have employed polymerase chain reaction (PCR) using the VNTR marker (MCT118). Although all the patients showed haemopoietic engraftment with donor cells, their BMF were found, by Southern blot analysis and PCR method, to be of the recipient origin. These data indicate that bone marrow-derived fibroblastic stromal cells which proliferate in long-term cultures are not transplantable in the conditioning regimens used for allogeneic BMT in humans.

摘要

骨髓微环境由成纤维细胞、内皮细胞、脂肪细胞和巨噬细胞组成,通过产生多种细胞因子在造血和淋巴细胞生成中发挥重要作用。因此,就异基因骨髓移植(BMT)后的血液学和免疫重建而言,研究这些细胞在异基因骨髓移植后的起源具有重要意义。我们在7例性别不匹配的病例中研究了长期培养的成纤维细胞基质细胞的起源。这是通过使用Y染色体特异性cDNA探针(PHY10)进行原位杂交来完成的,同时保留细胞的形态。原位杂交分析表明,所有性别不匹配病例长期培养中的骨髓成纤维细胞(BMF)均起源于受体。我们还在性别不匹配的病例中使用PHY10探针进行了Southern印迹分析,并在2例性别匹配的病例中使用了可变数目串联重复序列(VNTR)探针,该探针可检测DNA多态性。此外,我们使用VNTR标记(MCT118)进行了聚合酶链反应(PCR)。尽管所有患者均显示供体细胞的造血植入,但通过Southern印迹分析和PCR方法发现他们的BMF起源于受体。这些数据表明,在长期培养中增殖的骨髓来源的成纤维细胞基质细胞在用于人类异基因BMT的预处理方案中不可移植。

相似文献

1
Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans.人类骨髓移植后各阶段骨髓来源的成纤维细胞基质细胞的受体来源
Br J Haematol. 1991 Nov;79(3):359-65. doi: 10.1111/j.1365-2141.1991.tb08041.x.
2
Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia.
Bone Marrow Transplant. 1992 Sep;10(3):255-9.
3
Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation.
Br J Haematol. 1994 Feb;86(2):436-8. doi: 10.1111/j.1365-2141.1994.tb04764.x.
4
Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.通过高变DNA区域扩增早期检测骨髓植入。
Haematologica. 1997 Mar-Apr;82(2):156-60.
5
Detection of engraftment and chimerism after bone marrow transplantation by in situ hybridization using a Y-chromosome specific probe.
Am J Hematol. 1990 Apr;33(4):255-60. doi: 10.1002/ajh.2830330408.
6
Usefulness of Y-body study on bone marrow smears to demonstrate the origin of fibroblast stromal cells in allogeneic bone marrow transplantation.
Blut. 1990 Jul;61(1):14-6. doi: 10.1007/BF01739427.
7
Host origin of marrow stromal cells following allogeneic bone marrow transplantation.异基因骨髓移植后骨髓基质细胞的宿主来源
Nature. 1987;328(6129):429-32. doi: 10.1038/328429a0.
8
Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.利用DNA多态性监测非处理骨髓的异基因骨髓移植后的嵌合状态。
Leukemia. 1993 May;7(5):679-87.
9
Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation.通过原位杂交确定骨髓移植后骨髓基质细胞的起源和造血嵌合体。
Br J Cancer. 1990 Mar;61(3):385-9. doi: 10.1038/bjc.1990.84.
10
Y-body study in bone marrow precursors, peripheral blood cells and alveolar macrophages for demonstration of haemopoietic engraftment in allogeneic bone marrow transplantation.
Eur J Haematol. 1988 May;40(5):424-9. doi: 10.1111/j.1600-0609.1988.tb00851.x.

引用本文的文献

1
A Systematic Review of the Evidence of Hematopoietic Stem Cell Differentiation to Fibroblasts.造血干细胞向成纤维细胞分化证据的系统评价
Biomedicines. 2022 Nov 28;10(12):3063. doi: 10.3390/biomedicines10123063.
2
Nuclear shape, protrusive behaviour and in vivo retention of human bone marrow mesenchymal stromal cells is controlled by Lamin-A/C expression.核形状、突起行为和人骨髓间充质基质细胞的体内保留受核纤层蛋白 A/C 表达的控制。
Sci Rep. 2019 Oct 7;9(1):14401. doi: 10.1038/s41598-019-50955-x.
3
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
间充质基质细胞的归巢与迁移:如何提高细胞治疗的疗效?
World J Stem Cells. 2016 Mar 26;8(3):73-87. doi: 10.4252/wjsc.v8.i3.73.
4
Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow.小鼠骨髓中多能间充质干细胞的前瞻性鉴定、分离及全身移植
J Exp Med. 2009 Oct 26;206(11):2483-96. doi: 10.1084/jem.20091046. Epub 2009 Oct 19.
5
Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia.人类成纤维细胞的造血干细胞起源:性别错配干细胞移植女性受者和慢性髓系白血病患者的细胞培养研究。
Exp Hematol. 2009 Dec;37(12):1464-71. doi: 10.1016/j.exphem.2009.09.008. Epub 2009 Sep 26.